Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $335,981 - $407,957
-27,790 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $368,217 - $420,462
27,790 New
27,790 $377,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $1.17 Million - $1.59 Million
-85,771 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $1.23 Million - $1.61 Million
85,771 New
85,771 $1.61 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.